Nika Pharmaceuticals, Inc (NIKA) Assets (2021 - 2023)
Nika Pharmaceuticals' (NIKA) quarterly Assets came in at $864.0 in Q4 2023, little changed YoY from $864.0 in Q4 2022, and down 92.08% on a QoQ basis from $10910.0 in Q3 2023.
Nika Pharmaceuticals, Inc (NIKA) Assets (2021 - 2023) Analysis & Trends
Nika Pharmaceuticals (NIKA) has 3 years of Assets data on file, last reported at $864.0 in Q4 2023.
- Quarterly Assets changed 0.0% year-over-year to $864.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $864.0 (changed 0.0% YoY) and the FY2023 annual result came in at $864.0, changed 0.0% from the prior year.
- Assets declined to $864.0 in Q4 2023, from $10910.0 in the prior quarter.
- In the past five years, Assets ranged from a high of $11053.0 in Q2 2023 to a low of $83.0 in Q1 2022.
- A 3-year average of $4565.7 and a median of $3914.0 in 2022 frame the typical range for Assets.
- The widest YoY moves for Assets: up 5272.29% in 2023, down 0.0% in 2023.
- Tracing NIKA's Assets over 3 years: stood at $399.0 in 2021, then surged by 116.54% to $864.0 in 2022, then changed by 0.0% to $864.0 in 2023.
- The last three Assets figures came in at $864.0 (Q4 2023), $10910.0 (Q3 2023), and $11053.0 (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 864.00 |
| Sep 30, 2023 | 10,910.00 |
| Jun 30, 2023 | 11,053.00 |
| Mar 31, 2023 | 4,459.00 |
| Dec 31, 2022 | 864.00 |
| Sep 30, 2022 | 3,914.00 |
| Jun 30, 2022 | 8,545.00 |
| Mar 31, 2022 | 83.00 |
| Dec 31, 2021 | 399.00 |